Atrial Fibrillation

Featured Article

Understanding Obesity's Role in Atrial Fibrillation

Understanding Obesity's Role in Atrial Fibrillation

The comorbid conditions of obesity and atrial fibrillation require better prevention and treatment strategies.

Latest Features

Weighing Benefits and Risks of Anticoagulation in the Elderly

Weighing Benefits and Risks of Anticoagulation in the Elderly

Determining which patients who have atrial fibrillation should receive anticoagulation therapy for stroke prophylaxis can be challenging.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

New ACC/AHA performance and quality measures for atrial fibrillation/flutter include metrics for outpatient care.

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Experts weigh in on cryoablation vs radiofrequency ablation techniques for atrial fibrillation in light of FIRE and ICE trial results.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Risk and prevalence of stroke in patients with undiagnosed asymptomatic atrial fibrillation remains problematic for patients and clinicians.

Latest News

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Although stable sinus rhythm was achieved in some patients after LAA isolation, embolic stroke and LAA thrombus formation was still problematic.

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

The delayed start of anticoagulation treatment for atrial fibrillation has been linked to an increase risk for dementia.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.

Atrial Fibrillation Risk Reduced With Diabetes Medications

Atrial Fibrillation Risk Reduced With Diabetes Medications

Thiazolidinediones reduced the risk of atrial fibrillation by 30% in an analysis of pooled data from 7 studies.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

A systematic review of BMI and major adverse events in AF concluded that further evidence is necessary to clarify the relationship between obesity and AF.

Can Apixaban Reduce Intracranial Hemorrhage Risk vs Warfarin in Afib?

Can Apixaban Reduce Intracranial Hemorrhage Risk vs Warfarin in Afib?

Patients with atrial fibrillation taking apixaban showed significantly less intracranial hemorrhage compared with patients taking warfarin.

Prevalence of Inadequate Therapeutic Anticoagulation for Afib Preceding Ischemic Stroke Examined

Prevalence of Inadequate Therapeutic Anticoagulation for Afib Preceding Ischemic Stroke Examined

Inadequate therapeutic anticoagulation prior to the occurrence of ischemic stroke was found to be prevalent.

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Uninterrupted Anticoagulation With Dabigatran Improves Atrial Fibrillation Ablation Outcomes, Expert Q&A

Incidence of major bleeding events was lower with dabigatran vs warfarin in atrial fibrillation ablation.

Sign Up for Free e-Newsletters